FNBP2 Activators
FNBP2, functioning in actin cytoskeleton remodeling, cell migration, and neuronal development, can be indirectly activated by a range of chemical compounds that influence these cellular processes. Compounds like ROCK inhibitors (e.g., Y-27632), Latrunculin A, and Jasplakinolide, which modulate actin dynamics, create a cellular environment where FNBP2's role becomes more crucial. ROCK inhibitors, for instance, by damping down one pathway of cytoskeletal control, potentially increase the dependency on FNBP2 for maintaining proper cytoskeletal function, especially in neuronal cells. Latrunculin A and Jasplakinolide, by disrupting and stabilizing actin filaments, respectively, create a demand for FNBP2 activity in re-establishing or balancing actin dynamics.
Furthermore, agents like Nocodazole, Forskolin, and various kinase inhibitors (FAK, PI3K, Rac1, Cdc42) that affect different aspects of cell motility and cytoskeletal arrangement indirectly necessitate enhanced FNBP2 activity. Nocodazole's disruption of microtubules, Forskolin's elevation of cAMP levels, and the inhibition of key kinases involved in cell adhesion and actin remodeling, all potentially lead to a compensatory upregulation of FNBP2. This upregulation ensures the maintenance of cellular dynamics, particularly in contexts like axonal growth and neuronal development. These chemical compounds, by targeting different but interconnected pathways, underscore the versatile role of FNBP2 in various aspects of cellular functioning, highlighting its adaptability and importance in cellular homeostasis and development.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitors can modulate the actin cytoskeleton remodeling. By inhibiting ROCK, there can be a compensatory increase in FNBP2 activity to maintain cytoskeletal dynamics, especially in neuronal cells. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
An actin polymerization inhibitor, Latrunculin A disrupts actin filaments. This disruption can necessitate an upregulation of FNBP2 activity to re-establish cytoskeletal integrity. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
As an actin stabilizer, Jasplakinolide can increase the demand for actin remodeling proteins like FNBP2 to balance actin dynamics in cells. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
A microtubule depolymerizing agent, Nocodazole can indirectly enhance FNBP2 activity by altering the microtubule-actin crosstalk, thus influencing cytoskeletal remodeling. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
By increasing cAMP levels, Forskolin can influence actin cytoskeleton remodeling. Enhanced cAMP levels might upregulate FNBP2 function in neuronal development and migration. | ||||||
FAK Inhibitor 14 | 4506-66-5 | sc-203950 sc-203950A | 10 mg 50 mg | $109.00 $238.00 | 86 | |
Inhibiting FAK, involved in cell migration and adhesion, can shift the cellular reliance to FNBP2 for maintaining cytoskeletal dynamics and cellular motility. | ||||||
6-N-[2-[[4-(2,4-dichlorophenyl)-5-(1H-imidazol-2-yl)pyrimidin-2-yl]amino]ethyl]-3-nitropyridine-2,6-diamine | 556813-39-9 | sc-207421 | 5 mg | $278.00 | 1 | |
As Rac1 influences actin remodeling, its inhibition can upregulate FNBP2 activity to maintain cellular dynamics, especially in neuronal cells. | ||||||
INCB28060 | 1029712-80-8 | sc-364510 sc-364510A | 10 mg 50 mg | $305.00 $750.00 | ||
Inhibiting Cdc42, which is involved in actin polymerization, could increase the reliance on FNBP2 for cytoskeletal remodeling and neuronal development. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
As an inhibitor of the N-WASP, Wiskostatin can indirectly enhance FNBP2's role in actin dynamics by altering the balance of actin remodeling proteins. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
An inhibitor of actin polymerization, Cytochalasin D's disruption of actin filaments can lead to an increased requirement for FNBP2 in re-establishing cytoskeletal integrity. | ||||||